期刊文献+

晚期糖基化终产物增加动脉粥样硬化病变部位的炎症反应 被引量:11

Advanced glycosylation end products increase cellular inflammation in atherosclerotic plaques
原文传递
导出
摘要 目的通过整体模型探讨晚期糖基化终产物(AGEs)负荷对动脉粥样硬化斑块炎症反应程度的影响。方法50只新西兰白兔随机分为5组。A组:喂饲高胆固醇饲料,同时注射AGEs修饰的兔血清白蛋白(AGEs—RSA);B组:喂饲高胆固醇饲料,同时注射未加修饰的兔血清白蛋白(RSA);C组:单纯喂饲高胆固醇饲料;D组:喂饲普通饲料;E组:喂饲普通饲料,同时注射AGEs—RSA。10周后分离主动脉全段,油红O染色测定主动脉粥样斑块内脂质含量;免疫组化法计数斑块内浸润的巨噬细胞、T淋巴细胞以及平滑肌细胞的迁移增生。结果喂饲高胆固醇饲料各组动物主动脉均可见粥样硬化斑块形成,斑块病变部位可见不同程度的脂质沉积、巨噬细胞、T淋巴细胞浸润及平滑肌细胞迁移增生。A组粥样斑块中脂质含量[(71.86±8.30)%]显著多于B组[(53.76±3.72)%]和C组[(56.67±9.20)%](P<0.05);粥样硬化斑块病变部位浸润的巨噬细胞[(23.1±8.5)个/0.01 mm2]、T淋巴细胞[(15.1±3.8)个/0.01 mm2]和平滑肌细胞[(19.2±5.7)个/0.01.mm2]较B组[巨噬细胞(14.4±5.9)个/0.01 mm2、T淋巴细胞(9.1±2.6)个/0.01 mm2、平滑肌细胞(12.9±3.8)个/0.01mm2]和C组[巨噬细胞(15.4±4.4)个/0.01mm2、T淋巴细胞(10.5±2.2) 个/0.01 mm2、平滑肌细胞(13.8±3.9)个/0.01 Objective To test the hypothesis that advanced glycosylation end products(AGEs) increase cellular inflammation in atherosclerotic plaques. Methods Fifty rabbits were randomly divided into five groups. Hypercholesterolemic (0.5% cholesterol in diet) rabbits received repeated intravenous injection of either AGEs modified rabbit serum albumin (AGEs-RSA ) (group A) or unmodified RSA (group B) for 10 weeks. Rabbits treated with either hypercholesterolemic diet (group C)or with a normal diet(group D) or with a normal diet, and intravenous injection of AGEs-RSA (group E) were served as controls. Aortas were harvested at the 10th week, and lipid deposition was quantitated by oil red 0 staining. Macrophage (RAM-11 positive cells) and T lymphocyte (CD43 positive cells) infiltration, smooth muscle cell(α-actin positive cells) migration and proliferation were determined by using immunohistochemical staining and image-analysis techniques. Results Atherosclerotic plaques could be found in animals fed with hypercholesterolemic diet.Lipid deposition in plaque was significantly higher in group A (71.86%±8.3%) than those in group B (53.76%±3.72%)and group C (56.67%±9.2%). Infiltrations of macrophage[ (23.1±8.5)/0.01 mm2]and T lymphocyte[ (15.1 ± 3.8)/0.01 mm2]as well as migration and proliferation of smooth muscle cell [ (19.2±5.7)/0,01 mm2] in atherosclerotic lesions were significantly increased in animals treated with hypercholesterolemic diet and received injection of AGEs-RSA (group A) when compared with group B [macrophage (14.4± 5.9)70.01 mm2; T lymphocyte (9.1±2.6)/0.01 mm2; smooth muscle cell (12.9±3.8)/0.01 mm2]and group C[macrophage (15.4±4.4)/0.01 mm2; T lymphocyte (10.5±2.2)/0.01 mm2, smooth muscle cell (13.8±3.9)/0.01 mm2]. Neither plaque nor a cellular inflammation was found in animals fed with normal diet (group D)and in those received repeated injections of AGEs-RSA (group E). Conclusion AGEs increase cellular inflammation in atherosclerotic plaques and may accelerate formation of atherosclerosis in AGEs associated diseases.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2005年第6期360-363,共4页 Chinese Journal of Nephrology
基金 国家自然科学基金重点项目(30330300)国家自然科学基金(30470806)
  • 相关文献

参考文献14

  • 1Ross R. Atherosclerosis-an inflammatory disease. N Eng J Med, 1999, 340: 115-126.
  • 2Miyata T, Kurokawa K. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int, 2000,76: S120-S125.
  • 3Kalousava M, Skrha J, Zina T. Advanced glycation endproducts and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res, 2002,51: 597-604.
  • 4Hou FF, Owen WF Jr. Beta 2-microglobulin amyloidosis:role of monocytes/macrophages. Curr Opin Nephrol Hypertens,2002, 11: 417-421.
  • 5Hou FF, Chertow GM, Kay J, et al. Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis. Kidney Int,1997, 51: 1514-1519.
  • 6刘志强,侯凡凡,王力,舒友梅.ELISA法检测人血清晚期糖基化终产物及在血液透析病人的应用[J].解放军医学杂志,2000,25(6):391-393. 被引量:11
  • 7Rishad MF, Paul ED. Mechanisms of monocyte recruitment and accumulation. Br Heart J, 1993, 69:S19-S29.
  • 8Marcello R, Massimo P, Elisabetta B, et al. New markers of accelerated atherosclerosis in end-stage renal disease. J Nephrol, 2003, 16: 11-20.
  • 9Libby P, Rider PM, Maseri A, et al. Inflammation and atherosclerosis. Circulation, 2002,105: 1135-1143.
  • 10Kaneda H, Taguchi J, Ogasawara K, et al. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis, 2002, 162: 221-225.

二级参考文献57

  • 1张卫茹,侯凡凡,刘尚喜,郭志坚,周展眉,王国保,富宁,刘志强,王力,周玫.晚期糖基化终产物通过氧化应激加速动脉粥样硬化斑块形成[J].中华医学杂志,2004,84(13):1066-1070. 被引量:29
  • 2申洪,陆药丹.免疫组织化学染色的定量方法研究[J].生物医学工程学杂志,1993,10(4):281-284. 被引量:127
  • 3侯凡凡,张训.透析相关性淀粉样病变发病机理的进展[J].中华肾脏病杂志,1996,12(5):311-313. 被引量:7
  • 4[10]Hou FF, Jiang JP, Guo JQ et al. Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis. J Am Soc Nephrol,2002,13(5):1296
  • 5[11]Schmidt A M, Mora R, Cao R et al. The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and lactoferrin-like polypeptide. J Biol Chem,1994,269(13):9882
  • 6[12]Owen WF Jr, Hou FF, Stuart RO et al. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. Kidney Int, 1998, 53(5):1365
  • 7[13]Mercie P, Seigneur M, Bilhou-Nabera C et al. Nuclear transcription factor kappa B(NF- kappa B). Rev Med Interne ,1998,19:945
  • 8[14]Griending KK, Sorescu D et al. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol, 2000,20(10):2175
  • 9[2]Ritz E. Minor renal dysfunction: an emerging independent cardiovascular risk factor. Heart, 2003,89:963
  • 10[3]Muntner P, He J, Hamm L et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745

共引文献72

同被引文献134

引证文献11

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部